CRISPR Therapeutics to Participate in Upcoming Investor Conferences

On November 2, 2021 CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, reported that members of its senior management team are scheduled to participate in the following virtual investor conferences in November (Press release, CRISPR Therapeutics, NOV 2, 2021, View Source [SID1234594142]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Credit Suisse 30th Annual Healthcare Conference
Date: Monday, November 8, 2021
Time: 1:00 p.m. ET.

Barclays Gene Editing & Gene Therapy Summit
Date: Monday, November 15, 2021
Time: 10:00 a.m. ET

A live webcast of the events will be available on the "Events & Presentations" page in the Investors section of the Company’s website at View Source A replay of the webcasts will be archived on the Company’s website for 14 days following each presentation.